Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Cells ; 10(3)2021 03 20.
Article in English | MEDLINE | ID: mdl-33804755

ABSTRACT

Plants have historically been a rich source of successful anticancer drugs and chemotherapeutic agents, with research indicating that this trend will continue. In this contribution, we performed high-throughput cytotoxicity screening of 702 extracts from 95 plant species, representing 40 families of the Brazilian Cerrado biome. Activity was investigated against the following cancer cell lines: colon (Colo205 and Km12), renal (A498 and U031), liver (HEP3B and SKHEP), and osteosarcoma (MG63 and MG63.3). Dose-response tests were conducted with 44 of the most active extracts, with 22 demonstrating IC50 values ranging from <1.3 to 20 µg/mL. A molecular networking strategy was formulated using the Global Natural Product Social Molecular Networking (GNPS) platform to visualize, analyze, and annotate the compounds present in 17 extracts active against NCI-60 cell lines. Significant cytotoxic activity was found for Salacia crassifolia, Salacia elliptica, Simarouba versicolor, Diospyros hispida, Schinus terebinthifolia, Casearia sylvestris var. lingua, Magonia pubescens, and Rapanea guianensis. Molecular networking resulted in the annotation of 27 compounds. This strategy provided an initial overview of a complex and diverse natural product data set, yielded a large amount of chemical information, identified patterns and known compounds, and assisted in defining priorities for further studies.


Subject(s)
Ecosystem , High-Throughput Screening Assays , Plant Extracts/analysis , Plant Extracts/pharmacology , Brazil , Cell Line, Tumor , Geography , Humans , Inhibitory Concentration 50 , Solvents
2.
Molecules ; 23(6)2018 06 20.
Article in English | MEDLINE | ID: mdl-29925807

ABSTRACT

The new pentacyclic triterpene 11ß-hydroxypristimerin (1), along with the known metabolites pristimerin (2), 6-oxopristimerol (3) and vitideasin (4), were isolated from a Salacia crassifolia root wood extract, following a bioassay-guided fractionation approach. Both the extract and the purified triterpenes displayed pronounced cytotoxic activity against human cancer cell lines. The NCI-60 cell line screen revealed that compound 2 was the most active, with a mean GI50 of 0.17 µM, while compound 1 had a mean GI50 of 8.7 µM. A COMPARE analysis of the screening results showed that pristimerin is likely to be the main compound responsible for the cytotoxic activity of the extract (mean GI50 of 0.3 µg·mL−1). A targeted search for pristimerin and related derivatives using LC-MS/MS revealed the presence of pristimerin (2) and 6-oxopristimerol (3) in all Celastraceae species examined and in all plant parts tested, while vitideasin (4) was only detected in the genus Salacia.


Subject(s)
Celastraceae/metabolism , Metabolomics/methods , Plant Extracts/chemistry , Salacia/chemistry , Triterpenes/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/metabolism , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Humans , Pentacyclic Triterpenes , Plant Roots/chemistry , Structure-Activity Relationship , Triterpenes/isolation & purification , Triterpenes/metabolism , Triterpenes/therapeutic use
3.
J Nat Prod ; 80(6): 1893-1899, 2017 06 23.
Article in English | MEDLINE | ID: mdl-28570825

ABSTRACT

Bone-loss-related diseases such as rheumatoid arthritis, osteomyelitis, osteoporosis, and periodontitis are associated with high rates of morbidity worldwide. These disorders are characterized by an imbalance between the formation and activity of osteoblasts and osteoclasts, leading to bone loss. In this context, we evaluated the effect of cinnamoyloxy-mammeisin (CNM), an anti-inflammatory coumarin found in Melipona scutellaris geopropolis, on key targets related to bone remodeling. In the present study we investigated the in vitro effects of CNM on osteoclast differentiation and M-CSF+RANKL-induced osteoclastogenic marker expression. Additionally, the interference of CNM treatment on osteoclast activity was evaluated by zymography and resorption area. Finally, we assessed the capacity of the compound to mitigate alveolar bone loss in vivo in experimental murine periodontitis induced by Porphyromonas gingivalis. We observed that treatment with CNM impaired osteoclast differentiation, as evidenced by a reduced number of tartrate-resistant acid-phosphatase-positive multinucleated cells (TRAP+) as well as the expression of osteoclastogenic markers upon M-CSF+RANKL-induced stimulation. Similarly, we observed reduced gelatinolytic and resorption capacity in M-CSF+RANKL-induced cells in vitro. Lastly, CNM attenuated alveolar bone loss in an experimental murine periodontitis model. These findings indicate that CNM may be considered a promising treatment for bone loss diseases.


Subject(s)
Coumarins/pharmacology , Osteoclasts/drug effects , Periodontitis/drug therapy , Porphyromonas gingivalis/drug effects , Alveolar Bone Loss/drug therapy , Animals , Bone Resorption , Cell Differentiation/drug effects , Coumarins/chemistry , Macrophage Colony-Stimulating Factor , Mice , Molecular Structure , Osteoblasts/drug effects , Periodontitis/chemically induced , RANK Ligand/pharmacology
4.
J Nat Prod ; 79(7): 1828-33, 2016 07 22.
Article in English | MEDLINE | ID: mdl-27367493

ABSTRACT

Chemical compounds belonging to the class of coumarins have promising anti-inflammatory potential. Cinnamoyloxy-mammeisin (CNM) is a 4-phenylcoumarin that can be isolated from Brazilian geopropolis. To our knowledge, its anti-inflammatory activity has never been studied. Therefore, the present study investigated the anti-inflammatory activity of CNM and elucidated its mechanism of action on isolated macrophages. Pretreatment with CNM reduced neutrophil migration into the peritoneal and joint cavity of mice. Likewise, CNM reduced the in vitro and in vivo release of TNF-α and CXCL2/MIP-2. Regarding the possible molecular mechanism of action, CNM reduced the phosphorylation of proteins ERK 1/2, JNK, p38 MAPK, and AP-1 (subunit c-jun) in PG-stimulated macrophages. Pretreatment with CNM also reduced NF-κB activation in RAW 264.7 macrophages stably expressing the NF-κB-luciferase reporter gene. On the other hand, it did not alter IκBα degradation or nuclear translocation of p65. Thus, the results of this study demonstrate promising anti-inflammatory activity of CNM and provide an explanation of its mechanism of action in macrophages via inhibition of MAPK signaling, AP-1, and NF-κB.


Subject(s)
Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Coumarins/isolation & purification , Coumarins/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Brazil , Coumarins/chemistry , Cyclooxygenase 2/metabolism , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Mice , Molecular Structure , NF-kappa B/antagonists & inhibitors , Nitric Oxide Synthase Type II/antagonists & inhibitors , Signal Transduction/drug effects , Transcription Factor AP-1 , Tumor Necrosis Factor-alpha/pharmacology , eIF-2 Kinase/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
5.
J Nat Prod ; 78(2): 315-9, 2015 Feb 27.
Article in English | MEDLINE | ID: mdl-25587934

ABSTRACT

Two new sesquiterpenoid tropolone glycosides, liriosmasides A (1) and B (2), along with two known compounds, secoxyloganin and oplopanpheside C, were isolated from a methanol extract of the roots of Liriosma ovata. The structures of 1 and 2 were elucidated by spectroscopic methods including 1D and 2D NMR and by high-resolution mass spectrometry involving an ultra-high-performance liquid chromatography-quadrupole-orbital ion trap mass spectrometric (UHPLC-Q-Orbitrap MS) method. Compound 1 showed weak inhibitory activity against HIV RNase H.


Subject(s)
Glycosides/isolation & purification , Olacaceae/chemistry , Sesquiterpenes/isolation & purification , Tropolone/analogs & derivatives , Tropolone/isolation & purification , Chromatography, High Pressure Liquid/methods , Glycosides/chemistry , Glycosides/pharmacology , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Peru , Plant Roots/chemistry , Ribonuclease H/antagonists & inhibitors , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacology , Tropolone/chemistry , Tropolone/pharmacology
6.
J Nat Prod ; 71(9): 1634-6, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18763827

ABSTRACT

Three new galloyl arbutins, hyemalosides A-C (1-3), along with nine known compounds were isolated from the evergreen tree Eugenia hyemalis. The structures of compounds 1-3 were determined by analysis of NMR and MS data. Compounds 1-3 inhibited HIV-1 RNase H in vitro with IC50 values of 1.46, >18, and 1.19 microM, respectively. However, in a XTT-based cell viability assay using the human T-cell line CEM-SS infected with HIV-1 RT, none of the compounds inhibited the cytopathic effect of HIV-1 infection at the highest dose tested (20 microg/mL).


Subject(s)
Anti-HIV Agents/isolation & purification , Anti-HIV Agents/pharmacology , Arbutin/analogs & derivatives , Arbutin/isolation & purification , Arbutin/pharmacology , Gallic Acid/analogs & derivatives , Gallic Acid/isolation & purification , Gallic Acid/pharmacology , HIV-1/drug effects , HIV-1/enzymology , Plants, Medicinal/chemistry , Ribonuclease H, Human Immunodeficiency Virus/antagonists & inhibitors , Syzygium/chemistry , Anti-HIV Agents/chemistry , Arbutin/chemistry , Gallic Acid/chemistry , HIV-1/genetics , Humans , Molecular Structure , Paraguay
SELECTION OF CITATIONS
SEARCH DETAIL